Online Program

Smoking prevalence for persons in addiction treatment exceeds national prevalence in 23 countries

Wednesday, November 6, 2013 : 8:50 a.m. - 9:10 a.m.

Emma Passalacqua, BA, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA
Joseph Guydish, PhD, MPH, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA
Barbara Tajima, EdM, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA
Background: Tobacco-related disease accounts for nearly 6 million deaths worldwide each year (WHO). While tobacco use is decreasing in many countries, prevalence remains high in subgroups. Prior research in the U.S. found that smoking prevalence was 70% among persons enrolled in addictions treatment, compare to a 19% national prevalence. This paper was designed to learn whether very high tobacco use prevalence among persons enrolled in addiction treatment programs is also observed internationally. Methods: Electronic literature search in PubMed and PsychINFO. Search parameters included papers published 1987-2012, available in English, reporting from studies outside the U.S. Search terms such as “tobacco, patients, and substance-related disorders” were used to capture papers reporting tobacco use prevalence in addiction treatment samples. Results: 4529 abstracts were reviewed and 39 papers were found reporting smoking rates for persons receiving addiction treatment in 23 countries. Smoking rates ranged from 33-100%. Most papers reported smoking rates over 50%, and 28 papers reported rates above 75%. In every case, prevalence of tobacco use in addiction treatment samples was 2-3 times higher than national prevalence for the same country and the same time period. Conclusions: While international tobacco control efforts have achieved significant successes, they have not reached to persons in addictions treatment systems, where very high tobacco use prevalence is reported. This is true in the U.S. and worldwide. Further reducing prevalence of tobacco use, among current users, will require interventions and policy initiatives directed to this population, and other populations where prevalence is highest.

Learning Areas:

Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Analyze smoking prevalence in addiction treatment populations internationally.

Keyword(s): Tobacco, Substance Abuse Treatment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: The research of our team concerns access, delivery, and organization of addiction treatment services. In recent years we conducted systematic reviews of smoking prevalence among persons in addictions treatment, developed measures of tobacco-related knowledge, attitudes and treatment practices used in addiction programs, and tested an organizational intervention designed to increase tobacco dependence services in addiction treatment programs. Recently, we investigated the impacts of a statewide ban on smoking in treatment programs in New York State.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.